Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms
Authors
Keywords
-
Journal
Early Intervention in Psychiatry
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-03-21
DOI
10.1111/eip.12544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized trial
- (2017) T. Pawełczyk et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis
- (2017) J. Firth et al. PSYCHOLOGICAL MEDICINE
- Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis
- (2017) Joseph Firth et al. SCHIZOPHRENIA BULLETIN
- Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
- (2017) Patrick D. McGorry et al. JAMA Psychiatry
- Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
- (2016) Jerome Sarris et al. AMERICAN JOURNAL OF PSYCHIATRY
- A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis
- (2016) Scott B. Teasdale et al. BRITISH JOURNAL OF NUTRITION
- Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: What is the evidence?
- (2016) Dienke J. Bos et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
- (2016) Abderrahim Oulhaj et al. JOURNAL OF ALZHEIMERS DISEASE
- Adjunctive Taurine in First-Episode Psychosis
- (2016) Colin P. O’Donnell et al. JOURNAL OF CLINICAL PSYCHIATRY
- A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia
- (2016) Tomasz Pawełczyk et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis
- (2016) Jie Yin Yee et al. PSYCHIATRY RESEARCH
- Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior
- (2015) Rhonda P. Patrick et al. FASEB JOURNAL
- Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
- (2015) M H Rapaport et al. MOLECULAR PSYCHIATRY
- A randomised trial of nutrient supplements to minimise psychological stress after a natural disaster
- (2015) Bonnie J. Kaplan et al. PSYCHIATRY RESEARCH
- Serum vitamin D and hippocampal gray matter volume in schizophrenia
- (2015) Venkataram Shivakumar et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
- (2015) G. Paul Amminger et al. Nature Communications
- Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia
- (2014) K.A. Graham et al. Early Intervention in Psychiatry
- Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression
- (2014) Olivia M. Dean et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Serum levels of BDNF, folate and homocysteine: In relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia
- (2014) Xueqin Song et al. SCHIZOPHRENIA RESEARCH
- A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia
- (2014) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Meta-Analysis of Oxidative Stress in Schizophrenia
- (2013) Joshua Flatow et al. BIOLOGICAL PSYCHIATRY
- Edited by Kiriakos Xenitidis and Colin Campbell
- (2013) Julian J. Rucklidge et al. BRITISH JOURNAL OF PSYCHIATRY
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Eicosapentaenoic Acid Interventions in Schizophrenia
- (2012) Paolo Fusar-Poli et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The dietary pattern of patients with schizophrenia: A systematic review
- (2012) Salvatore Dipasquale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
- (2012) E. Jaaskelainen et al. SCHIZOPHRENIA BULLETIN
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Stress and Inflammation Reduce Brain-Derived Neurotrophic Factor Expression in First-Episode Psychosis
- (2011) Valeria Mondelli et al. JOURNAL OF CLINICAL PSYCHIATRY
- Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
- (2011) Urs Meyer et al. PHARMACOLOGY & THERAPEUTICS
- Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: A longitudinal T2 relaxometry pilot study
- (2010) Stephen J. Wood et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism
- (2009) Anvita Kale et al. PSYCHIATRY RESEARCH
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- High-fat, energy-dense, fast-food–style breakfast results in an increase in oxidative stress in metabolic syndrome
- (2008) Sridevi Devaraj et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study
- (2008) Gregor E Berger et al. NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started